Proteon Therapeutics is a late-stage biopharmaceutical company committed to improving the lives of patients and families affected by kidney and vascular diseases. The Company is developing potentially transformative solutions to address some of the most urgent needs of patients with chronic kidney disease requiring hemodialysis and peripheral artery disease with the goal of redefining how these diseases are treated. Proteon's lead product candidate, Vonapanitase, is a first-in-class, phase 3 investigational drug designed to treat vessel injury that leads to blood vessel blockage and reduced blood flow. These complications can prevent a patient from undergoing life-saving hemodialysis and result in corrective procedures, excess costs and patient trauma.
Type | Public | |
Founded | 2001 | |
HQ | Waltham, MA, US | Map |
Website | proteontherapeutics.com |
USD | |
---|---|
Net income (Q1, 2020) | (10.1m) |
EBIT (Q1, 2020) | (10.2m) |
Market capitalization (9-Jan-2020) | 18.5m |
Closing stock price (9-Jan-2020) | 33.4 |
Cash (31-Mar-2020) | 36.1m |
EV | (15.8m) |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.9m | ||||||||||||||||
General and administrative expense | 1.0m | 2.0m | 1.9m | 2.0m | 2.5m | 2.6m | 2.3m | 2.2m | 2.1m | 2.0m | 2.3m | 2.2m | 2.3m | 2.6m | 3.3m | 1.4m | 7.1m |
R&D expense | 1.8m | 2.6m | 3.1m | 3.1m | 4.3m | 5.2m | 4.8m | 4.2m | 3.9m | 10.3m | 4.1m | 2.8m | 2.4m | 4.0m | 2.1m | 206.0k | 3.1m |
Operating expense total | 2.8m | 4.6m | 5.0m | 5.1m | 6.8m | 7.9m | 7.2m | 6.5m | 6.0m | 12.3m | 6.4m | 5.0m | 4.6m | 6.6m | 5.4m | 1.6m | 10.2m |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 3.2m | 9.8m | 16.8m | 36.0m | 24.1m | 34.2m | 26.7m | 34.1m | 18.4m | 20.0m | 25.4m | 12.5m | 18.2m | 16.8m | 10.8m | 9.3m | 36.1m |
Prepaid Expenses | 168.0k | 1.2m | 1.1m | 829.0k | 1.1m | 1.2m | 1.7m | 1.3m | 1.3m | 554.0k | 1.2m | 1.1m | 871.0k | 1.0m | 614.0k | 277.0k | 3.6m |
Current Assets | 21.9m | 80.7m | 75.8m | 71.4m | 60.4m | 54.9m | 48.7m | 35.4m | 33.0m | 48.0m | 38.0m | 27.5m | 27.1m | 17.9m | 11.5m | 9.6m | 39.7m |
PP&E | 86.0k | 80.0k | 102.0k | 221.0k | 208.0k | 374.0k | 396.0k | 338.0k | 309.0k | 280.0k | 236.0k | 219.0k | 200.0k | 105.0k | 83.0k | 655.8k |
USD | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (10.6m) | (4.6m) | (9.7m) | (15.0m) | (6.6m) | (14.5m) | (21.6m) | (6.5m) | (12.1m) | (24.4m) | (6.1m) | (11.0m) | (15.5m) | (6.5m) | (11.8m) | (13.4m) | (10.1m) |
Depreciation and Amortization | 21.0k | 8.0k | 17.0k | 33.0k | 24.0k | 52.0k | 87.0k | 40.0k | 77.0k | 115.0k | 32.0k | 61.0k | 83.0k | 174.0k | 196.0k | 279.0k | 49.8k |
Accounts Payable | 1.3m | 296.0k | 366.0k | 488.0k | (367.0k) | 730.0k | 869.0k | (2.1m) | (942.0k) | 4.0m | (220.0k) | (7.0m) | (6.7m) | 155.0k | (1.0m) | (1.5m) | 1.9m |
Cash From Operating Activities | (7.9m) | (3.9m) | (8.5m) | (12.4m) | (5.9m) | (11.5m) | (18.1m) | (7.4m) | (10.7m) | (16.7m) | (5.5m) | (15.8m) | (18.9m) | (5.1m) | (11.0m) | (12.5m) | (7.1m) |
USD | Q3, 2014 |
---|---|
Financial Leverage | -0.2 x |
When was Proteon Therapeutics founded?
Proteon Therapeutics was founded in 2001.
Who are Proteon Therapeutics key executives?
Proteon Therapeutics's key executives are Timothy Noyes and George Eldridge.
How many employees does Proteon Therapeutics have?
Proteon Therapeutics has 17 employees.
Who are Proteon Therapeutics competitors?
Competitors of Proteon Therapeutics include Biogen, MyoKardia and Athersys.
Where is Proteon Therapeutics headquarters?
Proteon Therapeutics headquarters is located at 200 West St, Waltham.
Where are Proteon Therapeutics offices?
Proteon Therapeutics has an office in Waltham.
How many offices does Proteon Therapeutics have?
Proteon Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies